Error found with arthritis medication as 'stop using immediately' message issued
Share this @internewscast.com

A batch of arthritis medication is being recalled due to a labelling error. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday that some packs had been distributed to pharmacies with incorrect labels.

The MHRA revealed that manufacturer Maxearn Limited had informed them that the label on an imported batch of Depo-Medrone had been “released to the market with an error”. They stated that the vial label contained incorrect information regarding volume and total vial content.

The MHRA clarified: “The label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate). The error could result in the administration of the incorrect dose.

“Maxearn has contacted their distributor, 32 packs have been distributed to pharmacies. The remaining units provided to the distributor have been quarantined.

“The error only impacts the parallel imported product repackaged by Maxearn, packs from other sources are not affected and should continue to be dispensed.”

Dep-Medrone is injected directly into joints and soft tissues for the treatment of rheumatoid arthritis, osteoarthritis, bursitis and similar inflammatory conditions.

The MHRA has assured patients there is no need for alarm after instructing healthcare providers to cease distribution of the affected batch immediately.

It added: “Maxearn can confirm 32 packs were released by the distributor. All other units have been held before onward distribution. Maxearn will arrange for customers who received these units to be contacted.

“Healthcare professionals who have been supplied this batch and have administered the medicine to patients should contact the patient to make them aware of this error and provide any relevant clinical advice.”

For those concerned, the MHRA clarified: “No further action is required by patients as this is a pharmacy and wholesaler level recall. Depo-Medrone is administered under the supervision of a healthcare professional. Patients who have received this batch will be contacted by your healthcare professional.

“Patients who experience adverse reactions or have any questions about the medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.”

Share this @internewscast.com
You May Also Like

28-Year-Old Bride-to-Be, Initially Told Her Cancer Was Acid Reflux, Vows to Cherish Her Last Year with Her Toddler Son After Terminal Diagnosis

Six short months ago, as the nights were drawing in and her…

Science-Backed Hair Loss Remedy for Only 32p Claims to Enhance Growth

Hair loss can be distressing. However, a doctor has backed an unexpected…

Mastering a Firm Handshake: Could Emulating Donald Trump Lead to a Longer Life?

President Donald Trump’s notable handshakes often manage to find their way into…

How Profit-Driven Companies Might Influence the Quality of Care You Receive from Medical Professionals: A Perspective by John Naish

Would you trust NHS screening tests if it turned out they weren’t…

New Concerns Arise as Doctors Observe Rapid Increase in Cancer Rates, Outpacing Colon Cancer – Popular Food Item May Be Linked

Experts have warned of an alarming surge in a little-known type of…

Daily Consumption of Favorite Canned Food Led to Poisoning – Discovering the Shocking Safety Limits

An office worker has claimed eating tuna three times a day for…

Voters Express Concern: No Significant NHS Improvements Under Labour Before Next Election

Labour has failed to make any notable improvements to the NHS and…

Warning: Common Procedure May Increase Risk of Ultra-Deadly ‘Widow-Maker’ Heart Attack for Thousands

Thousands of people with the most dangerous type of heart disease could suffer…

Warning: Extended Sleep Might Increase Mortality Risk; Study Highlights Optimal Two-Hour Window

Researchers have discovered a connection between sleep duration and mortality risk. And…

UK Achieves Cancer Breakthrough with Blood Test to Tailor Treatments

UK scientists have created a blood test that reveals exactly how active…

Comprehending Parkinson’s Disease Progression: What to Anticipate in Each Stage

Have you ever thought about how someone’s body gradually begins to fail…

Doctor Cautions Against a Bedtime Routine That May Increase Dementia Risk

Falling asleep to the soothing sound of white noise could lead to…